JPMorgan upgraded Corteva (CTVA) to Overweight from Neutral with an unchanged price target of $70. Corteva announced a plan to split into two companies in the second half of 2026, a seed company and a crop chemical company, the analyst tells investors in a research note. The firm does not believe the split announcement has lowered the value of Corteva, and upgrades the shares following yesterday’s selloff.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva’s Strategic Split: Unlocking Value and Growth Potential with a Buy Rating
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Corteva to separate into two publicly traded companies
- Oppenheimer maintains bullish stance on Corteva following split reports
- Morning Movers: Tesla jumps after CEO buys 2.57M shares